Elderly Kidney Transplant Recipients: Single-Center Experience in the Middle East.
Adult
Age Factors
Aged
Aged, 80 and over
Donor Selection
Female
Graft Rejection
/ immunology
Graft Survival
/ drug effects
Humans
Immunosuppressive Agents
/ therapeutic use
Kidney Transplantation
/ adverse effects
Kuwait
Male
Middle Aged
Retrospective Studies
Risk Factors
Transplant Recipients
Treatment Outcome
Journal
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
ISSN: 2146-8427
Titre abrégé: Exp Clin Transplant
Pays: Turkey
ID NLM: 101207333
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
entrez:
20
2
2019
pubmed:
20
2
2019
medline:
25
6
2019
Statut:
ppublish
Résumé
The number of renal transplants in elderly patients is increasing as age per se does not constitute a contraindication to transplant. We compared renal transplant outcomes in elderly recipients versus a group of middle-aged patients. Our retrospective casecontrolled study compared elderly transplant recipients (n = 252; > 60 y old) with a matched cohort of younger adult recipients (n = 710; between 40 and 60 years old) who underwent renal transplant at the Hamed Al-Essa Organ Transplant Center of Kuwait between 2000 and 2014. Demographic characteristics, comorbidities, complications after transplant, and graft and patient outcomes were compared between groups. There were 252 elderly kidney transplant recipients (mean age of 65.5 ± 4.8 y; 59.52% males) and 710 younger adult patients (mean age of 49.3 ± 5.5 years; 61.4% males). Most donors were males in their thirties. Deceased donors predominated in the younger adult group, whereas living unrelated donors predominated in the elderly group (P < .05). Diabetes represented the most common cause of endstage kidney disease. Younger patients tended to receive heavier induction therapy but comparable maint enance immunosuppression. Posttransplant diabetes was higher in younger patients; however, there were more elderly patients with micro- and macroangiopathies (P < .05). No significant differences were shown between groups with regard to patient or graft survival (P > .05). This could be attributed to a significantly higher number of patients with cardiovascular risks, less rejection episodes, and higher number of malignancies in the elderly group (P < .05). Due to relatively less potent immunosuppression, elderly patients experienced lower rejection rates and better graft survival; however, patient survival was lower due to higher cardiovascular risk factors. Older patients should not be discouraged from living-donor renal transplant. Targeted research studies on protocols for the elderly are needed.
Identifiants
pubmed: 30777539
doi: 10.6002/ect.MESOT2018.P6
doi:
Substances chimiques
Immunosuppressive Agents
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM